Suggest OTCs for Seasonal Allergies Instead of Montelukast
April 2020
New boxed warnings for montelukast (Singulair) will raise questions about managing seasonal allergies...as spring ramps up.
Cases of mental health effects (depression, suicide, etc) are still being reported with montelukast...despite prior precautions.
FDA now says that montelukast’s benefits may NOT outweigh risks...especially for most patients with “hay fever.”Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote